ReviewCurrent opinion in biotechnology2019

Exploiting BBB disruption for the delivery of nanocarriers to the diseased CNS.

Benjamin J Umlauf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.